icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
 
 
 
High Efficacy of Ledipasvir/Sofosbuvir Plus Ribavirin Among Patients With Decompensated Cirrhosis Who Underwent Liver Transplant During Participation in the SOLAR-1 and -2 Studies
 
 
  Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
 
Beat Mullhaupt,1 Paul Kwo,2 Kosh Agarwal,3 Christophe Duvoux,4 Francois Durand,5 Markus Peck-Radosavljevic,6 Eric M. Yoshida,7 Leslie Lilly,8 Bernard Willems,9 Hugo E. Vargas,10 Princy Kumar,11
Robert S. Brown,12 Yves Horsmans,13 Shampa De-Oertel,14 Sarah Arterburn,14 Hadas Dvory-Sobol,14 Diana M. Brainard,14 John G. McHutchison,14 Norah Terrault,15 Mario Rizzetto16
1University Hospital Zurich, Switzerland; 2Indiana University School of Medicine, Indianapolis, Indiana, USA; 3The Institute of Liver Studies, King's College London, UK; 4Hopital Henri Mondor, Universite Paris-Est Creteil, Creteil, France; 5H˘pital Beaujon, Clichy, Assistance Publique-Hopitaux de Paris, Universite Paris Diderot-Paris 7, France; 6Medical University of Vienna, Austria; 7Vancouver General Hospital, University of British Columbia, Vancouver, Canada;
8Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; 9Centre Hospitalier de de Montreal, Quebec, Canada; 10Mayo Clinic, Phoenix, Arizona, USA; 11Georgetown University, Washington, DC, USA; 12Columbia University Medical Center/New York-Presbyterian, New York, New York, USA; 13Universite Catholique de Louvain, Belgium; 14Gilead Sciences, Inc., Foster City, California, USA; 15University of California, San Francisco; 16L'Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di To

EASL1

EASL2

EASL3

EASL4

EASL5

EASL6

EASL7

EASL8